• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有机阴离子转运多肽(OATP)家族转运体对非索非那定在人体肝脏摄取中的作用。

Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans.

作者信息

Shimizu Maki, Fuse Kaori, Okudaira Kazuho, Nishigaki Ryuichiro, Maeda Kazuya, Kusuhara Hiroyuki, Sugiyama Yuichi

机构信息

Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

出版信息

Drug Metab Dispos. 2005 Oct;33(10):1477-81. doi: 10.1124/dmd.105.004622. Epub 2005 Jul 13.

DOI:10.1124/dmd.105.004622
PMID:16014768
Abstract

Fexofenadine hydrochloride (FEX), a second generation H(1)-receptor antagonist, is mainly eliminated from the liver into bile in unchanged form. Recent studies have shown that FEX can be accepted by human MDR1 (P-glycoprotein), OATP1A2 [organic anion-transporting polypeptide (OATP)-A, and OATP2B1 (OATP-B)] expression systems. However, other transporters responsible for the hepatic uptake of FEX have not yet been identified. In the present study, we evaluated the contribution of OATP family transporters, namely OATP1B1 (OATP2/OATP-C), OATP1B3 (OATP8), and OATP2B1 (OATP-B), to FEX uptake using transporter-expressing HEK293 (human embryonic kidney) cells. The uptake of FEX in OATP1B3-expressing cells was significantly greater than that in vector-transfected cells. On the other hand, OATP1B1- or OATP2B1-mediated uptake of FEX was not statistically significant. OATP1B3-mediated transport could be explained by a one-saturable component with a Michaelis constant (K(m)) of 108 +/- 11 microM. The inhibitory effect of FEX on the uptake of estrone-3-sulfate (E(1)S), cholecystokinin octapeptide (CCK-8), and 17beta-estradiol-17beta-d-glucuronide (E(2)17betaG) was also examined. Both OATP1B1- and OATP1B3-mediated E(2)17betaG uptake was inhibited by FEX. The K(i) values were 148 +/- 61 and 205 +/- 72 microM for OATP1B1 and OATP1B3, respectively. FEX also inhibited OATP1B3-mediated CCK-8 uptake and OATP1B1-mediated E(1)S uptake with a K(i) value of 83.3 +/- 15.3 and 257 +/- 84 microM, respectively, suggesting that FEX could not be used as a specific inhibitor for OATP1B1 and OATP1B3, although FEX was preferentially accepted by OATP1B3. In conclusion, this is, to our knowledge, the first demonstration that OATP1B3 is thought to be a major transporter involved in hepatic uptake of FEX in humans.

摘要

盐酸非索非那定(FEX)是一种第二代H(1)受体拮抗剂,主要以原形从肝脏排泄至胆汁中。最近的研究表明,FEX能够被人MDR1(P-糖蛋白)、OATP1A2[有机阴离子转运多肽(OATP)-A]和OATP2B1(OATP-B)表达系统所摄取。然而,其他负责FEX肝脏摄取的转运体尚未被鉴定出来。在本研究中,我们利用表达转运体的HEK293(人胚肾)细胞评估了OATP家族转运体,即OATP1B1(OATP2/OATP-C)、OATP1B3(OATP8)和OATP2B1(OATP-B)对FEX摄取的贡献。在表达OATP1B3的细胞中FEX的摄取显著高于载体转染细胞。另一方面,OATP1B1或OATP2B1介导的FEX摄取无统计学意义。OATP1B3介导的转运可用一个米氏常数(K(m))为108±11μM的单饱和成分来解释。还研究了FEX对硫酸雌酮(E(1)S)、八肽胆囊收缩素(CCK-8)和17β-雌二醇-17β-D-葡萄糖醛酸苷(E(2)17βG)摄取的抑制作用。FEX抑制了OATP1B1和OATP1B3介导的E(2)17βG摄取。OATP1B1和OATP1B3的抑制常数(K(i))值分别为148±61和205±72μM。FEX还抑制了OATP1B3介导的CCK-8摄取和OATP1B1介导的E(1)S摄取,其K(i)值分别为83.3±15.3和257±84μM,这表明尽管FEX优先被OATP1B3摄取,但它不能用作OATP1B1和OATP1B3的特异性抑制剂。总之,据我们所知,这是首次证明OATP1B3被认为是参与人体肝脏摄取FEX的主要转运体。

相似文献

1
Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans.有机阴离子转运多肽(OATP)家族转运体对非索非那定在人体肝脏摄取中的作用。
Drug Metab Dispos. 2005 Oct;33(10):1477-81. doi: 10.1124/dmd.105.004622. Epub 2005 Jul 13.
2
Predominant contribution of OATP1B3 to the hepatic uptake of telmisartan, an angiotensin II receptor antagonist, in humans.在人类中,有机阴离子转运多肽1B3(OATP1B3)对血管紧张素II受体拮抗剂替米沙坦的肝脏摄取起主要作用。
Drug Metab Dispos. 2006 Jul;34(7):1109-15. doi: 10.1124/dmd.105.009175. Epub 2006 Apr 12.
3
The eighth and ninth transmembrane domains in organic anion transporting polypeptide 1B1 affect the transport kinetics of estrone-3-sulfate and estradiol-17beta-D-glucuronide.有机阴离子转运多肽1B1中的第八和第九个跨膜结构域影响硫酸雌酮和17β-D-葡萄糖醛酸雌二醇的转运动力学。
J Pharmacol Exp Ther. 2009 May;329(2):551-7. doi: 10.1124/jpet.108.148411. Epub 2009 Feb 24.
4
Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.吉非贝齐、氟伐他汀与其他有机阴离子转运多肽(OATP)底物在OATP1B1、OATP2B1和OATP1B3上的底物依赖性药物相互作用。
Drug Metab Dispos. 2007 Aug;35(8):1308-14. doi: 10.1124/dmd.106.012930. Epub 2007 Apr 30.
5
Investigation of the inhibitory effects of various drugs on the hepatic uptake of fexofenadine in humans.多种药物对非索非那定在人体肝脏摄取的抑制作用研究。
Drug Metab Dispos. 2008 Apr;36(4):663-9. doi: 10.1124/dmd.107.017814. Epub 2008 Jan 7.
6
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans.OATP2(OATP1B1)和OATP8(OATP1B3)对匹伐他汀在人体肝脏摄取中的作用。
J Pharmacol Exp Ther. 2004 Oct;311(1):139-46. doi: 10.1124/jpet.104.068056. Epub 2004 May 24.
7
Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.转运体在人类体内对血管紧张素II AT1受体选择性拮抗剂缬沙坦的肝脏摄取和胆汁排泄中的作用。
Drug Metab Dispos. 2006 Jul;34(7):1247-54. doi: 10.1124/dmd.105.008938. Epub 2006 Apr 19.
8
Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide.建立一组共表达有机阴离子转运多肽1B3和肝脏外排转运体的双转染细胞系,用于表征替米沙坦酰葡萄糖醛酸的肝胆转运。
Drug Metab Dispos. 2008 Apr;36(4):796-805. doi: 10.1124/dmd.107.018903. Epub 2008 Jan 7.
9
Functional characterization for polymorphic organic anion transporting polypeptides (OATP/SLCO1B1, 1B3, 2B1) of monkeys recombinantly expressed with various OATP probes.用各种OATP探针重组表达的猴子多态性有机阴离子转运多肽(OATP/SLCO1B1、1B3、2B1)的功能表征。
Biopharm Drug Dispos. 2019 Feb;40(2):62-69. doi: 10.1002/bdd.2171. Epub 2019 Feb 10.
10
Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.药物转运体的多种人类异构体参与了奥美沙坦(一种血管紧张素II AT1受体选择性拮抗剂)的肝脏和肾脏转运。
Drug Metab Dispos. 2007 Dec;35(12):2166-76. doi: 10.1124/dmd.107.017459. Epub 2007 Sep 6.

引用本文的文献

1
A Mechanistic Physiologically Based Pharmacokinetic (PBPK) modeling approach for fexofenadine: predictive pharmacokinetic insights in humans.非索非那定的基于生理的药代动力学(PBPK)机制建模方法:对人体药代动力学的预测性见解
Saudi Pharm J. 2025 Jul 9;33(4):24. doi: 10.1007/s44446-025-00024-4.
2
Bioanalytical HPLC method with fluorescence detector for determination of Entresto™ when co-administered with ibuprofen and fexofenadine: a pharmacokinetic study.采用荧光检测器的生物分析高效液相色谱法测定与布洛芬和非索非那定合用时的Entresto™:一项药代动力学研究。
RSC Adv. 2024 Jun 14;14(27):19197-19205. doi: 10.1039/d4ra02163k. eCollection 2024 Jun 12.
3
Uptake Transporters at the Blood-Brain Barrier and Their Role in Brain Drug Disposition.
血脑屏障处的摄取转运体及其在脑内药物处置中的作用。
Pharmaceutics. 2023 Oct 16;15(10):2473. doi: 10.3390/pharmaceutics15102473.
4
Severity of coeliac disease and clinical management study when using a non-metabolised medication: a phase I pharmacokinetic study.乳糜泻疾病严重程度和临床管理研究使用非代谢药物:一项 I 期药代动力学研究。
BMJ Open. 2023 Feb 24;13(2):e057151. doi: 10.1136/bmjopen-2021-057151.
5
Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients.预测非酒精性脂肪性肝炎患者药物药代动力学的改变及药物不良反应风险
Acta Pharm Sin B. 2023 Jan;13(1):1-28. doi: 10.1016/j.apsb.2022.08.018. Epub 2022 Aug 28.
6
Resolving the gene expression maps of human first-trimester chorionic villi with spatial transcriptome.利用空间转录组解析人类孕早期绒毛膜绒毛的基因表达图谱。
Front Cell Dev Biol. 2022 Dec 6;10:1060298. doi: 10.3389/fcell.2022.1060298. eCollection 2022.
7
Efficacy and Safety of Non-brain Penetrating H-Antihistamines for the Treatment of Allergic Diseases.非脑穿透性H-抗组胺药治疗过敏性疾病的疗效和安全性
Curr Top Behav Neurosci. 2022;59:193-214. doi: 10.1007/7854_2021_265.
8
Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model.手性药物氟西汀透过胎盘的药代动力学:P-糖蛋白抑制剂氟西汀对人胎盘灌注模型的影响。
Pharm Res. 2021 Apr;38(4):647-655. doi: 10.1007/s11095-021-03035-7. Epub 2021 Apr 6.
9
Effect of Extract, a Herbal Drug, on the Absorption of Fexofenadine.草药提取物对非索非那定吸收的影响。
Pharmaceutics. 2020 Jun 12;12(6):547. doi: 10.3390/pharmaceutics12060547.
10
Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug-Drug Interaction Studies.P-糖蛋白(P-gp)诱导剂对 P-gp 底物暴露的影响:临床药物-药物相互作用研究综述。
Clin Pharmacokinet. 2020 Jun;59(6):699-714. doi: 10.1007/s40262-020-00867-1.